IVAX Diagnostics, Inc. (IVD: Quote), a fully integrated in vitro diagnostics company, reported a narrower first-quarter net loss of $78,454 or breakeven per share, compared to the net loss of $1.0 million or $0.04 per share in the year-ago quarter.
Net revenues for the quarter rose 3.4 percent to $4.3 million from $4.1 million a year ago, mainly due to an increase in reagent and instrument sales in the United States and contract R&D revenues in Italy.
Operating expenses decreased to $2.2 million from $3.1 million in the year-ago first quarter.
Click here to receive FREE breaking news email alerts for ERBA Diagnostics Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org